Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Lara

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Marine Drugs|January 24, 2025
Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural MesotheliomaAngélica Luna-Nophal, Fernando Díaz-Castillo, Vanessa Izquierdo-Sánchez, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM populationDavid Heredia, Luis Mas, Andres F Cardona, et al.
The Oncologist|September 9, 2021
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic MalignanciesOscar Arrieta, Luis Lara-Mejía, Elysse Bautista-GonzÁlez, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2021
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 studyMónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, et al.
Frontiers in Oncology|December 19, 2025
Correction: Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Frontiers in Oncology|November 2, 2023
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Cancers|October 16, 2025
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. <i>Cancers</i> 2021, <i>13</i>, 6256Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.
Cancers|December 24, 2021
Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor BehaviorRubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.
Cancers|May 27, 2026
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. <i>Cancers</i> 2021, <i>13</i>, 6256Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.
Transplantation|July 10, 2024
Islet Isolation Outcomes in Patients Undergoing Total Pancreatectomy With Islet Autotransplantation in the POST ConsortiumJordan Mattke, Anne Eaton, Martin Wijkstrom, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Marine Drugs|January 24, 2025
Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural MesotheliomaAngélica Luna-Nophal, Fernando Díaz-Castillo, Vanessa Izquierdo-Sánchez, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM populationDavid Heredia, Luis Mas, Andres F Cardona, et al.
The Oncologist|September 9, 2021
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic MalignanciesOscar Arrieta, Luis Lara-Mejía, Elysse Bautista-GonzÁlez, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2021
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 studyMónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, et al.
Frontiers in Oncology|December 19, 2025
Correction: Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Frontiers in Oncology|November 2, 2023
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Cancers|October 16, 2025
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. <i>Cancers</i> 2021, <i>13</i>, 6256Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.
Cancers|December 24, 2021
Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor BehaviorRubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.
Cancers|May 27, 2026
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. <i>Cancers</i> 2021, <i>13</i>, 6256Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.
Transplantation|July 10, 2024
Islet Isolation Outcomes in Patients Undergoing Total Pancreatectomy With Islet Autotransplantation in the POST ConsortiumJordan Mattke, Anne Eaton, Martin Wijkstrom, et al.
Pageof 8